Some theories are emerging on the link between receiving a covid vaccine and the risks of myocarditis, including the possibility that vaccines were injected into the veins, directly affecting the heart. Pfizer’s covid pill, antibody drugs, risks to pregnant women and pets with covid are also in the news.
The Wall Street Journal: Covid-19 vaccines and myocarditis link probed by researchers
Some theories focus on the type of spike protein that a person makes in response to mRNA vaccines. The mRNA itself or other components of the vaccines, the researchers said, could also trigger certain inflammatory responses in some people. A new theory under review: inappropriate injections of the vaccine directly into a vein, which sends the vaccine to the heart muscle. To find answers, some doctors and scientists perform tests in laboratory dishes and examine heart tissue samples from people who have developed myocarditis or pericarditis after being vaccinated. (Loftus, 11/7)
AP: Pfizer says COVID-19 pill cut hospital, 90% risk of death
Pfizer Inc. said on Friday that its experimental antiviral pill for COVID-19 reduced hospitalization and death rates by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use drug. use to treat coronavirus. Currently, most COVID-19 treatments require an intravenous or injection. Competitor Merck’s COVID-19 pill is already under review by the Food and Drug Administration after showing strong initial results, and the UK on Thursday became the first country to accept it. (11/5)
NBC News: Anti-body Covid drugs could protect people with weak immune systems
Even as the Covid Delta Wave ebbs in the United States, millions of people with weakened immune systems remain trapped in anxious limbo and sequestered. A considerable portion of this population, according to research, remains highly vulnerable to the coronavirus even after three or four injections of the vaccine. Many immunocompromised Americans, including people with cancer, autoimmune diseases, and organ transplants, eagerly await what could be their ticket to returning to some semblance of normalcy: the ability to receive periodic injections of long-acting monoclonal antibodies. This, the research suggests, could provide them with substantial protection against Covid-19 that in their case vaccination cannot. (Ryan, 7/11)
The Boston Globe: Pregnant women with COVID-19 face higher rates of serious illness and premature births. Why are they so little vaccinated?
During the last month of her pregnancy last March, Amanda Piantedosi faced a dilemma. Her doctor urged her to get the COVID-19 vaccine. Her husband, parents, in-laws and friends strongly opposed this. Pregnant women infected with COVID-19 face higher rates of serious illness, preterm birth and other complications. But her family members, while eager to get the vaccine themselves, worried about whether a new vaccine would be safe for the baby. (Freyer, 11/7)
Covid even affects pets –
CIDRAP: Pets also vulnerable to heart complications from COVID-19
Pets are susceptible to the Alpha SARS-CoV-2 (B117) variant and can suffer from serious illness, according to a cat and dog case series published yesterday by UK researchers in Veterinary Record. The study looked at the illnesses of six pets, including four cats and two dogs. All had presented with acute heart disease, including severe myocarditis. Animals tested positive for the Alpha variant or had antibodies 2-6 weeks after illness. Many owners had been sick with COVID-19 before their pets got sick. (11/5)
This is part of the KHN Morning Briefing, a summary of coverage of health policies by major news organizations. Sign up for an email subscription.